Skip to content
10-K

Annual Report

ONCOVISTA INNOVATIVE THERAPIES, INC

0001144204-14-022406

← back to feed
Filed
Apr 14, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Apr 7, 2014 21.63M sh
Current Liabilities FY 2013 · Dec 31, 2012 $2.25M
Current Assets FY 2013 · Dec 31, 2012 $571.8K
Total Assets FY 2013 · Dec 31, 2012 $575.27K
Sga Expense FY 2013 · Dec 31, 2012 $881.01K
Rd Expense FY 2013 · Dec 31, 2012 $1.1M
Net Income FY 2013 · Dec 31, 2012 −$1.63M
Operating Income FY 2013 · Dec 31, 2012 −$1.98M
Revenue FY 2013 · Dec 31, 2012 $0
Cash And Equivalents FY 2013 · Dec 31, 2011 $2.13M
Stockholders Equity FY 2013 · Dec 31, 2011 −$124.03K